For traders
For forex traders: every release, and how currencies tend to react
Currencies move on data and central banks. Our calendar covers the U.S., euro area, UK, Japan, Canada, Australia, New Zealand, Switzerland and China, with what each surprise tends to do to the pair.
A global economic calendar
This week's releases and central-bank decisions in New York time, with impact ratings, forecasts and previous readings. Filter by currency and impact.
What each surprise tends to do
For every data release and rate decision: how the currency and its main pair have tended to react to a hotter or cooler result.
A countdown to the next big U.S. release
So you're never caught flat-footed by payrolls or CPI.
The dollar story
Fed, yields and U.S. data coverage, the biggest drivers of every major pair.
Right now
Market data by TradingView and Coinbase. Rates are the latest daily or weekly Federal Reserve data. Futures boards show 24-hour index and commodity prices that track futures markets. Some quotes may be delayed. Not investment advice.
Latest from the desk
Hassett asks why the Fed is hiking with core inflation at 2%; that 2% leans on a flat June
The White House economic adviser questioned last week's rate rise and criticized officials calling for more. Government data show core prices ran at about a 3% pace in July and August, and the two-year yield jumped to 4.85%.
FDA advisers back Grail's Galleri cancer blood test 7-2, but split 6-4 on whether it works
The panel said the benefits outweigh the risks, a first for a multi-cancer blood test. In Grail's main study the test caught about one in three cancers diagnosed within a year, and the stock had already jumped 34% before the vote.
Starboard builds a stake in Knife River and pushes for a sale or higher margins; stock rises after hours
The activist wants the aggregates and paving company to close its margin gap with peers or explore a sale, the WSJ reported. Knife River's own numbers show why a single margin point is worth about $5 a share.
Arcturus calls its OTC deficiency data encouraging; the Phase 2 had seven evaluable patients and no placebo
ARCT-810 lowered average ammonia and glutamine in a small open-label study, but Arcturus is already moving a next-generation drug into the same trial. The stock was little changed after hours.
U.S. and China extend the Busan trade truce to Jan. 10, moving the tariff deadline past the holidays
Treasury Secretary Scott Bessent said the truce due to lapse on Nov. 10 will now run to Jan. 10. The two extra months carry the deal past the first full-year test of China's soybean pledge and past peak holiday shipping.
Smurfit Westrock buys CMPC's Chile box business for $420 million, below its own valuation multiple
The packaging giant is paying less than 6 times post-synergy EBITDA for a Santiago paper mill and three box plants. On our math its own shares trade at about 7.6 times this year's guided EBITDA.
The Company Chronicle publishes market information and news, not investment advice.